Capture Hi-C reveals novel drug targets in rheumatic diseases

The paper discussed in this podcast provides an approach, using Capture Hi-C data, to link genetic associations to potential causal genes and assess the potential of drug repurposing in three rheumatic diseases. This has the potential to identify genes which are functionally relevant and the target of existing therapies, which could provide new ways to treat patients, enhancing their quality of life and reducing the economic impact on healthcare providers.

Read the full paper on the ARD website: https://ard.bmj.com/content/78/8/1127.